Stay updated on Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of the OReO study and its inclusion criteria, while adding references to Epithelial Ovarian Cancer and the revision version of the document.SummaryDifference27%
Stay in the know with updates to Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.